SCHEMBL7203587

SCHEMBL7203587

CSc1cccc(NC(=N)N(C)c2cc(Cl)ccc2Cl)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.51
MEN1 O00255 8/20 0.51
KMT2A Q03164 8/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2D6 P10635 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
RAB9A P51151 3/20 0.46
GAA P10253 1/20 0.46
NPC1 O15118 3/20 0.46
NPSR1 Q6W5P4 1/20 0.46
LMNA P02545 2/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
ALDH1A1 P00352 2/20 0.45
KDM4E B2RXH2 1/20 0.45
HTT P42858 1/20 0.45
SIGMAR1 Q99720 2/20 0.43
TP53 P04637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL620895 0.93 RAB9A (0.48) MAPTMEN1KMT2ACYP1A2CYP3A4
SCHEMBL6720595 0.88 MAPT (0.45) MAPTMEN1KMT2ACYP1A2CYP3A4
SCHEMBL6717398 0.86 SIGMAR1 (0.52) MAPTMEN1KMT2ACYP1A2CYP3A4
SCHEMBL6724396 0.84 RAB9A (0.41) MAPTMEN1KMT2ACYP1A2CYP3A4
SCHEMBL14862342 0.83 MEN1 (0.43) MAPTMEN1KMT2ACYP1A2CYP3A4
SCHEMBL6721212 0.83 SMN1; SMN2 (0.46) MAPTMEN1KMT2ACYP1A2CYP3A4
SCHEMBL6720838 0.83 RAB9A (0.39) MAPTMEN1KMT2ACYP1A2CYP3A4
SCHEMBL6727685 0.81 ALDH1A1 (0.46) MAPTMEN1KMT2ACYP1A2CYP3A4
SCHEMBL6727803 0.81 SIGMAR1 (0.63) SIGMAR1
SCHEMBL6720918 0.80 MEN1 (0.51) MAPTMEN1KMT2ACYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0705100-B1 THERAPEUTIC SUBSTITUTED GUANIDINES CENES LTD (GB) 2003-07-30 EP claimed
US-6156741-A Therapeutic substituted guanidines CAMBRIDGE NEUROSCIENCE, INC. (US) 2000-12-05 US claimed
EP-0918460-A1 METHODS OF TREATMENT OF EYE TRAUMA AND DISORDERS CAMBRIDGE NEUROSCIENCE, INC. (US) 1999-06-02 EP claimed
WO-1999002145-A1 COMBINATION DRUG THERAPIES COMPRISING AMINOGLYCOSIDE ANTIBIOTICS AND N,N'-DISUBSTITUTED GUANIDINES CAMBRIDGE NEUROSCIENCE, INC. (US) 1999-01-21 WO claimed
WO-1998004131-A1 METHODS OF TREATMENT OF EYE TRAUMA AND DISORDERS CAMBRIDGE NEUROSCIENCE, INC. (US) 1998-02-05 WO claimed
CN-1126434-A Therapeutic substituted guanidines CAMBRIDGE NEUROSCIENCE INC (US) 1996-07-10 CN claimed
WO-1999002145-A1 COMBINATION DRUG THERAPIES COMPRISING AMINOGLYCOSIDE ANTIBIOTICS AND N,N'-DISUBSTITUTED GUANIDINES CAMBRIDGE NEUROSCIENCE, INC. (US) 1999-01-21 WO disclosed
CN-1126434-A Therapeutic substituted guanidines CAMBRIDGE NEUROSCIENCE INC (US) 1996-07-10 CN disclosed